bronchial asthma
Conditions
Interventions
None listed
Sponsors
Tokyo Metropolitan Tama Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosed as having asthma according to "Global Strategy for Asthma Management and Prevention (2016 update)". 2. Having asthma symptoms in the past year while receiving three or more controller medication including medium dose of inhaled corticosteroid or two or more controller medication including high dose of inhaled corticosteroid. 3. Receiving three or more controller medication including medium dose of inhaled corticosteroid or two or more controller medication including high dose of inhaled corticosteroid for more than 30 days. 4. Having asthma symptoms in the past while receiving high dose of inhaled corticosteroid and long-acting beta2-agonist.
Exclusion criteria
Exclusion criteria: 1. Implantation of electoric device, such as a pacemaker. 2. Unable to receive medication which is used in the bronchoscopic procedure or in treatment of asthma exacerbation, such as lidocane, and systemic corticosteroid. 3. Previous history of bronchial thermoplasty or broncho-pulmonary surgery. 4. Severe complication such as respiratory infection, coagulation disorder, lung cancer, unstable ischemic heart disease and unstable cerebrovascular disease. 5. Unable to receive pulmonary function tests. 6. Intolerant of bronchoscopic procedure. 7. Women expecting a child or scheduled to be pregnant in 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Discovery of the predictive factors for the effectiveness at 3 months after the final session of bronchial thermoplasty against bronchial asthma | — |
Countries
Japan
Contacts
Public ContactKengo Murata
Tokyo Metropolitan Tama Medical Center Pulmonology
Outcome results
None listed